In this volume, we discuss recent studies on ADHD, such as risks related to prenatal exposure to ADHD medication, the safety and efficacy of alpha-2 adrenergic agonists for the treatment of ADHD in preschool children, and the potential link between early childhood anesthesia exposure and subsequent ADHD risk. Additionally, we examine the efficacy and safety of fish oil when used as an adjunctive agent for the treatment of depressive disorders in youth, as well as the risks associated with benzodiazepine use among children with sleep disorders.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-16-2780?utm_source=PDF+CME+Program&utm_medium=PDF+CME+Program&utm_campaign=PDF+CME+Program
- Start Date: 2023-11-01 05:00:00
- End Date: 2023-11-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest